BlackRock Fund Advisors - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 197 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$111,455,000
+0.9%
8,959,423
+11.0%
0.02%
-8.7%
Q3 2016$110,484,000
+90.9%
8,070,403
+3.0%
0.02%
+76.9%
Q2 2016$57,879,000
+14.9%
7,832,019
-0.6%
0.01%
+8.3%
Q1 2016$50,359,000
+0.8%
7,880,858
-1.4%
0.01%0.0%
Q4 2015$49,979,000
+4.0%
7,996,641
-2.8%
0.01%0.0%
Q3 2015$48,056,000
-29.8%
8,228,791
-0.6%
0.01%
-25.0%
Q2 2015$68,470,000
-0.6%
8,279,306
-1.0%
0.02%0.0%
Q1 2015$68,911,000
+26.2%
8,363,038
+5.2%
0.02%
+23.1%
Q4 2014$54,589,000
+38.9%
7,945,954
+9.2%
0.01%
+18.2%
Q3 2014$39,295,000
-4.2%
7,276,922
+13.0%
0.01%
-8.3%
Q2 2014$41,021,000
+41.1%
6,439,785
+78.5%
0.01%
+33.3%
Q1 2014$29,074,000
+18.2%
3,607,1760.0%0.01%
+28.6%
Q4 2013$24,601,000
-64.2%
3,607,176
-3.3%
0.01%
-69.6%
Q3 2013$68,644,000
+15.6%
3,730,636
+9.9%
0.02%
+4.5%
Q2 2013$59,393,0003,395,8200.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$80,313,00015.61%
Opaleye Management Inc. 1,310,000$8,188,0003.42%
Camber Capital Management LP 5,405,235$33,783,0002.18%
IRONWOOD INVESTMENT MANAGEMENT LLC 471,516$2,947,0001.22%
HighVista Strategies LLC 807,100$5,044,0000.94%
JS Capital Management LLC 630,000$3,938,0000.94%
1492 Capital Management LLC 202,500$1,266,0000.92%
Palo Alto Investors LP 2,257,217$14,108,0000.78%
Geduld E E 185,100$1,157,0000.72%
Elk Creek Partners, LLC 1,592,527$9,953,0000.71%
View complete list of ARIAD PHARMACEUTICALS INC shareholders